Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
364.4 INR | +2.49% | +2.58% | -0.31% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- With an expected P/E ratio at 124.85 and 50.9 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.31% | 59Cr | B | ||
+19.22% | 8.45TCr | C+ | ||
-27.14% | 7.22TCr | B- | ||
+4.65% | 2.77TCr | C+ | ||
-6.23% | 1.8TCr | B | ||
-0.36% | 1.75TCr | A- | ||
+3.30% | 1.58TCr | A- | ||
+7.44% | 1.36TCr | B- | ||
+6.56% | 1.33TCr | A- | ||
+73.32% | 1.33TCr | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HCG Stock
- Ratings HealthCare Global Enterprises Limited